A61P 13 - Drugs for disorders of the urinary system

Patents for A61P 13 - Drugs for disorders of the urinary system (56,135)
10/2004
10/07/2004	US20040198781 Carbonic anhydrase inhibitor
10/07/2004	US20040198775 Methods for treating lower urinary tract disorders and the related disorders vulvodynia and vulvar vestibulitis using Cav2.2 subunit calcium channel modulators
10/07/2004	US20040198766 Chemical compounds
10/07/2004	US20040198757 2-anilino-pyrimidine derivatives as cyclin dependent kinase inhibitors
10/07/2004	US20040198735 Sulfonyl heteroaryl triazoles as anti-inflammatory/analgesic agents
10/07/2004	US20040198720 3-(Arylamino)methylene-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors
10/07/2004	US20040198718 Naphthyridine derivatives, processes for their preparation, their use and pharmaceutical compositions comprising them
10/07/2004	US20040198717 4-(trifluoromethyl)-7,8,9,10-tetrahydrochromeno[7,6-b]azepin-2(6H)-one and derivatives;4-(trifluoromethyl)-1,6,7,8,9,10-hexahydro-2H-azepino[3,2-g]quinolin-2-one and derivatives; useful in the treating conditions caused by androgen deficiency such as bone disorders
10/07/2004	US20040198682 RNA interference mediated inhibition of placental growth factor gene expression using short interfering nucleic acid (siNA)
10/07/2004	US20040198651 Secreted proteins
10/07/2004	US20040197404 Extended release oral dosage form
10/07/2004	US20040197345 Prostate derived Ets factor
10/07/2004	US20040197341 Therapeutic process for p. aeruginosa infections using macrolide antibiotics
10/07/2004	CA2519761A1 Food for improving clinical conditions capable of lowering the concentration of low-molecular-weight nitrogen-containing compounds in blood
10/06/2004	EP1464339A1 Cell migration inhibitor
10/06/2004	EP1463817A2 Histamine receptor h3 polynucleotides
10/06/2004	EP1463812A2 Degp protease: cleavage site identification and proteolysis of a natural target in e. coli
10/06/2004	EP1463797A2 Methods of kidney transplantation utilizing developing nephric tissue
10/06/2004	EP1463756A2 Secreted proteins
10/06/2004	EP1463751A2 Albumin fusion proteins
10/06/2004	EP1463731A1 Dibenzodiazepine derivates, their preparation and use
10/06/2004	EP1463728A2 Fused cyclic modulators of nuclear hormone receptor function
10/06/2004	EP1463725A1 Process and intermediates for pyridazinone antidiabetic agents
10/06/2004	EP1463716A1 Pyrrolidine and piperidine derivates as nk1 antagonists
10/06/2004	EP1463714A2 Vanilloid receptor ligands and their use in treatments
10/06/2004	EP1463707A2 A group of novel anti-cancer compounds with specific structure
10/06/2004	EP1463525A2 Compositions and methods for the diagnosis and treatment of tumor
10/06/2004	EP1463509A1 Type 4 phosphodiesterase inhibitors and uses thereof
10/06/2004	EP1463503A1 Pharmaceutical composition comprising a glitazone and a 4-oxobutanoic acid, and the use thereof for treating diabetes
10/06/2004	EP1463497A2 Treating muscle wasting with selective androgen receptor modulators
10/06/2004	EP1463412A2 Composition comprising wenguanguo extracts, methods for preparing same and uses therof
10/06/2004	EP1232141B1 Ethers of o-desmethyl venlafaxine
10/06/2004	EP1165516B1 Heterocyclic urea and related compounds useful as anti-inflammatory agents
10/06/2004	EP1144403B1 Substituted pyrazoles as p38 kinase inhibitors
10/06/2004	EP0980252B1 Therapies for acute renal failure
10/06/2004	CN1535168A Controlled release composition and method of producing the same
10/06/2004	CN1535155A Pharmaceutical combination comprising either (S)-2-ethyxy-3 [4-(2-{4-methane sulfonyl oxyphenyl} ethoxy) phenyl] propanoic acid or 3-{4-[2-(4-tert-butoxy carbonylamino phenyl) ethoxy] phenyl}
10/06/2004	CN1534028A New azadicyclo salt kind compound and its use in treating protein aging disease
10/06/2004	CN1534010A Water soluble extract of red sage root and its preeparation method and use
10/06/2004	CN1533800A Medicinal composition for treating dysuria due to benign prostatauxe and its preparation method
10/06/2004	CN1533794A Special effect oral liquid for treating acute chronic nephritis
10/06/2004	CN1169808C 'Beta'-carboline compound
10/06/2004	CN1169534C Medicine for curing impotence
10/06/2004	CN1169529C Nano silver antimicrobial inflammation-relieving gel for curing prostatitis and its industrial production process
10/06/2004	CN1169522C Controlled release bead, of producing the same and multiple unit formulation comprising it
10/05/2004	US6800778 Process for producing optically active naphthalene derivative and optical resolver therefor
10/05/2004	US6800761 Form of irbesartan, methods for obtaining said form and pharmaceutical compositions containing same
10/05/2004	US6800654 Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1)
10/05/2004	US6800633 Pyrrolo[2,3d]pyrimidine compositions and their use
10/05/2004	US6800627 Central nervous system, cardiovascular and gastrointestinal disorders, diabetes inspidus, sleep apnea
10/05/2004	US6800626 For therapy and prophylaxis of inflammatory diseases, autoimmune diseases, destructive bone disorders, proliferative disorders, infectious diseases, neurodegenerative diseases, allergies, reperfusion/ischemia in stroke, heart attacks, etc.
10/05/2004	US6800620 Contacting leukocytes, osteoclasts with an enzyme inhibitors, a 9h-purin-3h-quinazolin-4-one derivatives, treating bone-resorption disorder, antiproliferative agents treating leukemia cells
10/05/2004	US6800619 Urea heterocycliccarbonyl-substituted aspartic or glutamic acid derivatives
10/05/2004	US6800455 Nucloetide sequences coding polypeptides for use in the diagnosis and treatment of heart, kidney and inflammatory defects
10/05/2004	US6800441 Heparanase specific molecular probes and their use in research and medical applications
10/05/2004	US6800299 Method of extracting lipids from marine and aquatic animal tissues
10/05/2004	CA2309439C 3-(3-hydroxyphenyl)-3-amino-propionamide derivatives
10/05/2004	CA2128956C Tricyclic diazepine vasopressin antagonists
09/2004
09/30/2004	WO2004083851A2 Diagnostics and therapeutics for diseases associated with trace amine receptor 1 (ta1)
09/30/2004	WO2004083245A2 Agent comprise an albumin-like first polypeptide bound to a second polypeptide
09/30/2004	WO2004083184A1 Receptor antagonist
09/30/2004	WO2004082696A1 Pharmaceutical composition and method for the treatment and prevention of prostatic hyperplasia and prostatitis using roystonea regia (royal palm) fruits
09/30/2004	WO2004082574A2 Diagnostics and therapeutics for diseases associated with dopamine receptor d5 (drd5)
09/30/2004	WO2004082567A2 Diagnostics and therapeutics for diseases associated with dopamine receptor d1a (drd1)
09/30/2004	WO2004038405A3 Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 43 (gpr43)
09/30/2004	WO2003087333A8 Modulation of stem and progenitor cell differentiation, assays, and uses thereof
09/30/2004	US20040194159 Cloning pigs using donor nuclei from differentiated cells
09/30/2004	US20040192943 Nf-kappab inhibitors
09/30/2004	US20040192916 Analgesics; neuropathic pain; headaches; muscle relaxants; incontence; tinnitus; diarrhea; antiarrhythmia agents; antiischemic agents; antiinflammatory agents; antiulcer agents; antidepressants; antiepileptic agents
09/30/2004	US20040192742 Antiarthritic agents; muscular dystrophy; antiinflammatory agents; glomerulonephritis; malaria; oral diseases
09/30/2004	US20040192716 Mixture with 2-amino-1,3-propanediol and excipients; synergistic mixture; concurrent administering
09/30/2004	US20040192701 Phenlypyridine carbonyl piperazine derivative
09/30/2004	US20040192685 Tetrahydroisoquinoline compounds as estrogen agonists/antagonists
09/30/2004	US20040191756 Transgenic rodent for diagnosing and identifying modulator for treatment and prevention inflammatory disorders
09/30/2004	US20040191236 Administering antigen associated with disease, a dendritic cell binding agent specific for the antigen, and an autologous dendritic cell; immunotherapy
09/30/2004	US20040191228 Methods of kidney transplantation utilizing developing nephric tissue
09/30/2004	US20040191211 Tissue-specific transporter inhibitor
09/30/2004	US20040191210 Compounds
09/30/2004	CA2519027A1 Agent comprise an albumin-like first polypeptide bound to a second polypeptide
09/29/2004	EP1461614A2 Functional inactivation of cxcr4-mediated responses in growth hormone transgenic mice through socs3 upregulation
09/29/2004	EP1461443A2 Carbohydrate-associated proteins
09/29/2004	EP1461336A2 1-alkyl-1-azoniabicyclo (2.2.2) octane carbamate derivatives and their use as muscarinic receptor antagonists
09/29/2004	EP1461323A2 Compounds for the treatment of metabolic disorders
09/29/2004	EP1461321A1 3,4-di-substituted pyridazinediones as cxc chemokine receptor antagonists
09/29/2004	EP1461313A1 Human adam-10 inhibitors
09/29/2004	EP1461311A2 Urea derivatives as vr1-antagonists
09/29/2004	EP1461122A2 Treatment of genitourinary tract disorders
09/29/2004	EP1461086A2 Enzymatic cleavable reagents for specific delivery to disease sites
09/29/2004	EP1461073A2 Peptide agonists of prostate-specific antigen, and uses therefor
09/29/2004	EP1461070A2 Combined use of a glp-1 compound and a modulator of diabetic late complications
09/29/2004	EP1461043A1 Oral pharmaceutical products containing 17 beta-estradiol-3 lower alkanoate, method of administering the same and process of preparation
09/29/2004	EP1461034A1 Substituted imidazolidines, method for the production thereof, use thereof as a drug or for diagnosis, and drug containing substituted imidazolidines
09/29/2004	EP1389202B1 2,6-substituted chroman derivatives useful as beta-3 adrenoreceptor agonists
09/29/2004	EP1351941B1 Bisaryl derivatives having fsh receptor modulatory activity
09/29/2004	EP1287001B1 Thiophene derivatives useful as anticancer agents
09/29/2004	EP1200400B1 Substituted pyrrolidin-2,3,4-trion derivatives useful as nmda-receptor antagonists
09/29/2004	EP1181278B1 Cyclic amine derivatives and their uses
09/29/2004	EP1019040B1 Aryl ureas for the treatment of inflammatory or immunomodulatory diseases
09/29/2004	EP1000059B1 Tricyclic vasopressin agonists
09/29/2004	EP0914146B1 Morphogen treatment for chronic renal failure

1 ... 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 ... 562